Valentin Fulga of Hemostemix
joined us at Stem Cells & Regenerative Medicine Congress 2014 to present '
Hemostemix
:
Your cells, our technology'
Download the presentation now to learn about
-
Advantages of ACP-01
-
Ischemic heart disease clinical trial results
-
Diversified development & commercialization opportunities
...and
much
more!
Get your copy here!
To find out more about
diversified development and commercialization opportunities from Hemostemix
, attend
Stem Cells & Regenerative Medicine Congress USA 2015 September 2-3
in Washington, DC.